Cyberonics/ANS
This article was originally published in The Gray Sheet
Executive Summary
Advanced Neuromodulation Systems drops $524 mil., $22-per-share bid for vagus nerve stimulation developer Cyberonics Oct. 1. Cyberonics, which offers VNS Therapy for epilepsy and is seeking an expanded indication for depression, had spurned merger talks and rejected the offer as inadequate (1"The Gray Sheet" Sept. 20, 2004, p. 5)...